Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:00 pm Sale |
2021-12-31 | 13G | Moderna, Inc. MRNA |
Flagship Ventures Fund IV General Partner LLC | 20,008,540 4.900% |
-13,134,971 (-39.63%) |
Filing History |
| 2022-02-14 3:00 pm Purchase |
2021-12-31 | 13G | Rubius Therapeutics, Inc. RUBY |
Flagship Ventures Fund IV General Partner LLC | 38,581,526 42.900% |
241,250 (+0.63%) |
Filing History |
| 2021-02-16 5:03 pm Purchase |
2020-12-31 | 13G | Rubius Therapeutics, Inc. RUBY |
Flagship Ventures Fund IV General Partner LLC | 38,340,276 47.400% |
43,750 (+0.11%) |
Filing History |
| 2021-02-16 5:02 pm Sale |
2020-12-31 | 13G | Moderna, Inc. MRNA |
Flagship Ventures Fund IV General Partner LLC | 33,143,511 8.400% |
-17,865,181 (-35.02%) |
Filing History |